YEN LAUER: Open Payments
NPI 1447758735 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 11 payments from 6 companies in 2025. Trend: 2023 $332 · 2024 $903 · 2025 $608
Food & beverage: $533Education: $75
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $249 |
| Ferring Pharmaceuticals Inc. | 2 | $141 |
| Sumitomo Pharma America, Inc. | 3 | $90 |
| Chiesi USA, Inc. | 1 | $75 |
| PFIZER INC. | 1 | $32 |
| Telix Pharmaceuticals | 1 | $21 |
Products named: ADSTILADRIN, RYBREVANT, ERLEADA, GEMTESA, CUROSURF, XTANDI, ILLUCCIX.
Industry payments across MA — which companies pay providers there.
